Literature DB >> 28171878

Antibacterial Defense of Human Airway Epithelial Cells from Chronic Obstructive Pulmonary Disease Patients Induced by Acute Exposure to Nontypeable Haemophilus influenzae: Modulation by Cigarette Smoke.

Gimano D Amatngalim1, Jasmijn A Schrumpf, Almira Henic, Esther Dronkers, Renate M Verhoosel, Soledad R Ordonez, Henk P Haagsman, Maria E Fuentes, Sriram Sridhar, Jamil Aarbiou, Richard A J Janssen, Annemarie N Lekkerkerker, Pieter S Hiemstra.   

Abstract

Antimicrobial proteins and peptides (AMPs) are a central component of the antibacterial activity of airway epithelial cells. It has been proposed that a decrease in antibacterial lung defense contributes to an increased susceptibility to microbial infection in smokers and patients with chronic obstructive pulmonary disease (COPD). However, whether reduced AMP expression in the epithelium contributes to this lower defense is largely unknown. We investigated the bacterial killing activity and expression of AMPs by air-liquid interface-cultured primary bronchial epithelial cells from COPD patients and non-COPD (ex-)smokers that were stimulated with nontypeable Haemophilus influenzae (NTHi). In addition, the effect of cigarette smoke on AMP expression and the activation of signaling pathways was determined. COPD cell cultures displayed reduced antibacterial activity, whereas smoke exposure suppressed the NTHi-induced expression of AMPs and further increased IL-8 expression in COPD and non-COPD cultures. Moreover, smoke exposure impaired NTHi-induced activation of NF-κB, but not MAP-kinase signaling. Our findings demonstrate that the antibacterial activity of cultured airway epithelial cells induced by acute bacterial exposure was reduced in COPD and suppressed by cigarette smoke, whereas inflammatory responses persisted. These findings help to explain the imbalance between protective antibacterial and destructive inflammatory innate immune responses in COPD.
© 2017 The Author(s) Published by S. Karger AG, Basel.

Entities:  

Keywords:  Antimicrobial peptides; Chronic obstructive pulmonary disease; Cigarette smoke; Epithelium; Host defense

Mesh:

Substances:

Year:  2017        PMID: 28171878      PMCID: PMC5569706          DOI: 10.1159/000455193

Source DB:  PubMed          Journal:  J Innate Immun        ISSN: 1662-811X            Impact factor:   7.349


  56 in total

1.  Exposure of differentiated airway epithelial cells to volatile smoke in vitro.

Authors:  Christoph Beisswenger; Juliane Platz; Carola Seifart; Claus Vogelmeier; Robert Bals
Journal:  Respiration       Date:  2004 Jul-Aug       Impact factor: 3.580

Review 2.  The regulation of AP-1 activity by mitogen-activated protein kinases.

Authors:  M Karin
Journal:  J Biol Chem       Date:  1995-07-14       Impact factor: 5.157

3.  The antimicrobial peptide cathelicidin interacts with airway mucus.

Authors:  Kerstin Felgentreff; Christoph Beisswenger; Matthias Griese; Tanja Gulder; Gerhard Bringmann; Robert Bals
Journal:  Peptides       Date:  2006-09-11       Impact factor: 3.750

Review 4.  COPD and the microbiome.

Authors:  Manoj J Mammen; Sanjay Sethi
Journal:  Respirology       Date:  2016-01-27       Impact factor: 6.424

Review 5.  Infection as a comorbidity of COPD.

Authors:  S Sethi
Journal:  Eur Respir J       Date:  2010-06       Impact factor: 16.671

6.  A novel host defense system of airways is defective in cystic fibrosis.

Authors:  Patryk Moskwa; Daniel Lorentzen; Katherine J D A Excoffon; Joseph Zabner; Paul B McCray; William M Nauseef; Corinne Dupuy; Botond Bánfi
Journal:  Am J Respir Crit Care Med       Date:  2006-11-02       Impact factor: 21.405

7.  The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses.

Authors:  David L Boone; Emre E Turer; Eric G Lee; Regina-Celeste Ahmad; Matthew T Wheeler; Colleen Tsui; Paula Hurley; Marcia Chien; Sophia Chai; Osamu Hitotsumatsu; Elizabeth McNally; Cecile Pickart; Averil Ma
Journal:  Nat Immunol       Date:  2004-08-29       Impact factor: 25.606

8.  Persistent colonization by Haemophilus influenzae in chronic obstructive pulmonary disease.

Authors:  Timothy F Murphy; Aimee L Brauer; Andrew T Schiffmacher; Sanjay Sethi
Journal:  Am J Respir Crit Care Med       Date:  2004-04-29       Impact factor: 21.405

9.  miR-147, a microRNA that is induced upon Toll-like receptor stimulation, regulates murine macrophage inflammatory responses.

Authors:  Gang Liu; Arnaud Friggeri; Yanping Yang; Young-Jun Park; Yuko Tsuruta; Edward Abraham
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-31       Impact factor: 11.205

10.  Reduced airway surface pH impairs bacterial killing in the porcine cystic fibrosis lung.

Authors:  Alejandro A Pezzulo; Xiao Xiao Tang; Mark J Hoegger; Mahmoud H Abou Alaiwa; Shyam Ramachandran; Thomas O Moninger; Phillip H Karp; Christine L Wohlford-Lenane; Henk P Haagsman; Martin van Eijk; Botond Bánfi; Alexander R Horswill; David A Stoltz; Paul B McCray; Michael J Welsh; Joseph Zabner
Journal:  Nature       Date:  2012-07-04       Impact factor: 49.962

View more
  26 in total

1.  Another Brick in the Wall.

Authors:  Heiko Herwald; Arne Egesten
Journal:  J Innate Immun       Date:  2019-02-26       Impact factor: 7.349

2.  Novel insights into the effects of cigarette smoke on the airway epithelial surface-lessons learned at the European Respiratory Society International Congress 2018 in Paris.

Authors:  Gimano D Amatngalim; Rodolfo Paula Vieira; Silke Meiners; Sabine Bartel
Journal:  J Thorac Dis       Date:  2018-09       Impact factor: 2.895

3.  TGF-β1 Impairs Vitamin D-Induced and Constitutive Airway Epithelial Host Defense Mechanisms.

Authors:  Jasmijn A Schrumpf; Dennis K Ninaber; Anne M van der Does; Pieter S Hiemstra
Journal:  J Innate Immun       Date:  2019-04-10       Impact factor: 7.349

4.  Modulation of Airway Epithelial Innate Immunity and Wound Repair by M(GM-CSF) and M(M-CSF) Macrophages.

Authors:  Sander van Riet; Annemarie van Schadewijk; Steve de Vos; Nick Vandeghinste; Robbert J Rottier; Jan Stolk; Pieter S Hiemstra; Padmini Khedoe
Journal:  J Innate Immun       Date:  2020-04-14       Impact factor: 7.349

5.  Effect of terbutaline plus doxofylline on chronic obstructive pulmonary disease.

Authors:  Qiuyan Luo; Xue Peng; Hua Zhang
Journal:  Am J Transl Res       Date:  2021-06-15       Impact factor: 4.060

6.  Air-liquid interface cultures of the healthy and diseased human respiratory tract: promises, challenges and future directions.

Authors:  Domizia Baldassi; Bettina Gabold; Olivia Merkel
Journal:  Adv Nanobiomed Res       Date:  2021-05-06

Review 7.  Animal Models Reflecting Chronic Obstructive Pulmonary Disease and Related Respiratory Disorders: Translating Pre-Clinical Data into Clinical Relevance.

Authors:  Lloyd Tanner; Andrew Bruce Single
Journal:  J Innate Immun       Date:  2019-09-17       Impact factor: 7.349

8.  Inhaled corticosteroid suppression of cathelicidin drives dysbiosis and bacterial infection in chronic obstructive pulmonary disease.

Authors:  Aran Singanayagam; Nicholas Glanville; Leah Cuthbertson; Nathan W Bartlett; Lydia J Finney; Elena Turek; Eteri Bakhsoliani; Maria Adelaide Calderazzo; Maria-Belen Trujillo-Torralbo; Joseph Footitt; Phillip L James; Peter Fenwick; Samuel V Kemp; Thomas B Clarke; Jadwiga A Wedzicha; Michael R Edwards; Miriam Moffatt; William O Cookson; Patrick Mallia; Sebastian L Johnston
Journal:  Sci Transl Med       Date:  2019-08-28       Impact factor: 17.956

9.  Plasma Cathelicidin is Independently Associated with Reduced Lung Function in COPD: Analysis of the Subpopulations and Intermediate Outcome Measures in COPD Study Cohort.

Authors:  Robert M Burkes; Agathe S Ceppe; David J Couper; Alejandro P Comellas; J Michael Wells; Stephen P Peters; Gerard J Criner; Richard E Kanner; Robert Paine; Stephanie A Christenson; Christopher B Cooper; Igor Z Barjaktarevic; Jerry A Krishnan; Wassim W Labaki; MeiLan K Han; Jeffrey L Curtis; Nadia N Hansel; Robert A Wise; M Bradley Drummond
Journal:  Chronic Obstr Pulm Dis       Date:  2020-10

10.  Bronchoalveolar Lavage and Plasma Cathelicidin Response to 25-Hydroxy Vitamin D Supplementation: A Pilot Study.

Authors:  Emily C Sanders; Robert M Burkes; Jason R Mock; Todd T Brown; Robert A Wise; Nadia N Hansel; Mark C Liu; M Bradley Drummond
Journal:  Chronic Obstr Pulm Dis       Date:  2021-07-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.